The DOI matches its Crossref record.
Successful Treatment of Infantile Hemangiomas with Interferon-α-2b
Abstract
PURPOSE: Hemangiomas are benign tumors occurring in 10% of infants. A small percentage are complicated by blockage of vital structures, consumptive coagulopathy, or heart failure, resulting in a mortality of -20% of patients with complications. Here, we describe four infants with complicated hemangiomas responding to interferon-alpha-2b therapy. PATIENTS AND METHODS: Four children with hemangiomas were treated with interferon-alpha-2b for complicating heart failure (1), visual impairment (2), or coagulopathy (1). Patients received interferon-alpha-2b alone or in conjunction with corticosteroid therapy over 2 to 9 months. Imaging studies and urinary basic fibroblast growth factor (bFGF) levels were used to monitor treatment response. RESULTS: Three of four patients demonstrated involution of the hemangiomas with improvement in their coagulopathy or visual impairment. The fourth patient expired due to cardiac complications despite radiologic evidence of hemangioma involution. Side effects associated with interferon-alpha-2b treatment included elevated transaminases (2) and leukocytosis (2), which resolved upon completion of therapy. One patient developed mild gross motor delay (1), which improved after cessation of therapy. Decreased urinary bFGF levels correlated with hemangioma involution. CONCLUSION: Interferon-alpha-2b therapy is an effective, well-tolerated treatment for complicated hemangiomas. Measurement of urinary bFGF levels may provide an objective method for monitoring treatment response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Angiogenesis: regulators and clinical applications
Liekens, S., De Clercq, E., & Neyts, J. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00529-3 · Cited by 748
Drolet, B. A., Esterly, N. B., & Frieden, I. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907153410307 · Cited by 586
Mulliken, J. B., Fishman, S. J., & Burrows, P. E. (2000) · Current Problems in Surgery · doi:10.1016/s0011-3840(00)80013-1 · Cited by 504
Bruckner, A. L., & Frieden, I. J. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.200 · Cited by 381
Kasabach–merritt syndrome: pathogenesis and management
Hall, G. W. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02453.x · Cited by 329
Metadata
- Authors
- Chang, E., Boyd, A., Nelson, C. C., Crowley, D., Law, T., Keough, K. M., Folkman, J., B. Ezekowitz, R. A., & Castle, V. P.
- Venue
- Journal of Pediatric Hematology/Oncology
- Published
- 1997-05
- Volume
- 19
- Issue
- 3
- Pages
- 237-244
- ISSN
- 1077-4114 (ISSN-L)
- OpenAlex
- W2330494542
- Cited by
- 191
- References
- 0
- FWCI
- 10.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Successful Treatment of Infantile Hemangiomas with Interferon-α-2b. https://app.cochat.ai/papers/10.1097/00043426-199705000-00011
- The paper
- Chang, E., Boyd, A., Nelson, C. C., Crowley, D., Law, T., Keough, K. M., Folkman, J., B. Ezekowitz, R. A., & Castle, V. P. (1997). Successful Treatment of Infantile Hemangiomas with Interferon-α-2b. Journal of Pediatric Hematology/Oncology. https://doi.org/10.1097/00043426-199705000-00011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.